Upstream Bio (UPB) Accumulated Depreciation (2023 - 2026)
Upstream Bio (UPB) posted quarterly Accumulated Depreciation of $393000.0 for Q1 2026, up 97.49% year-over-year from $199000.0 in Q1 2025, and up 14.24% quarter-over-quarter from $344000.0 in Q4 2025.
Upstream Bio (UPB) Accumulated Depreciation (2023 - 2026) Analysis & Trends
Upstream Bio's Accumulated Depreciation history runs 4 years deep, the most recent figure standing at $393000.0 for Q1 2026.
- In Q1 2026, Accumulated Depreciation rose 97.49% year-over-year to $393000.0; the TTM figure through Mar 2026 stood at $393000.0 (up 97.49% YoY), while the FY2025 annual figure was $344000.0, up 120.51% from the prior year.
- Accumulated Depreciation for Q1 2026 stood at $393000.0, up from $344000.0 in the prior quarter.
- The five-year high for Accumulated Depreciation was $393000.0 in Q1 2026, with the low at $67000.0 in Q4 2023.
- The 4-year median for Accumulated Depreciation is $220000.0 (2025), against an average of $224250.0.
- The sharpest annual moves came in 2025 and 2026: Accumulated Depreciation soared 168.22% in 2025, then jumped 97.49% in 2026.
- Upstream Bio's Accumulated Depreciation stood at $67000.0 in 2023, then jumped by 132.84% to $156000.0 in 2024, then jumped by 120.51% to $344000.0 in 2025, then advanced by 14.24% to $393000.0 in 2026.
- Business Quant data shows UPB's Accumulated Depreciation at $393000.0 in Q1 2026, $344000.0 in Q4 2025, and $287000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Upstream Bio | 387.23 Mn | 387.23 Mn | -3.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 443,000.00 |
| Mar 31, 2026 | 393,000.00 |
| Dec 31, 2025 | 344,000.00 |
| Sep 30, 2025 | 287,000.00 |
| Jun 30, 2025 | 241,000.00 |
| Mar 31, 2025 | 199,000.00 |
| Dec 31, 2024 | 156,000.00 |
| Sep 30, 2024 | 107,000.00 |
| Dec 31, 2023 | 67,000.00 |